🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📑 Impact of pain in patients with #cirrhosis?  Big‼️      1️⃣ 1/3 of pts have pain at time of  🩺 visit despite ⬆️ rates of analgesic 💊 use  2️⃣ >75% of pain is mod/sev, often in abdomen  3️⃣ Mod-sev pain associated w ⬆️ 🏥 use and ⬆️ mortality journals.lww.com/hepcomm/fullte…

📑 Rifaximin plus lactulose versus lactulose alone for reducing the risk of #HE recurrence‼️ Rifaximin➕lactulose was more efficacious than lactulose alone for: ⬇️ risk of OHE recurrence ⬇️ HE-related 🏥 journals.lww.com/hepcomm/fullte…

Camina por tu hígado! 26 de Abril , 10:00 AM! Inscríbete! World Liver Day

Are you based in Santiago de Chile? Join the walk for liver health on 26 April! Exercise, even in moderate amounts and intensity is one of the best ways to prevent liver disease. Details & registration below 👇#worldliverday 🚶‍♀️🚶 Asociación Chilena de Hepatología ALEH

Our team is hiring! If you want to help transform the care of people living with alcohol-associated liver disease (ALD) through research. Please join us: We are looking for a Research Program Manager for the ALD team at VCU Stravitz-Sanyal Institute for Liver Disease More details: tinyurl.com/28ey49uy

Recomiendo este TREMENDO podcast de oncología en español desarrollado por dos tremendos oncólogos de la Universidad Católica, en este capítulo conversando de que son los cuidados paliativos! open.spotify.com/episode/0VYu3U…

In this interim analysis of a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly semaglutide improved liver histologic results at 72 weeks. Full ESSENCE trial results: nej.md/3EVFAFM

Excelente iniciativa de ALEH con 2 de mis investigadores favoritos: Sebastian Marciano Juan Turnes #LiverTwitter #LiverX us02web.zoom.us/meeting/regist…

Time to rethink secondary SBP prophylaxis? Probably. We may actually be harming our patients, with patients prescribed Abx having ⬆️ infection Great study by Jasmohan Bajaj #AGAGastroSquad American Gastroenterological Association (AGA) AASLD

Secondary SBP prophylaxis 💊associated with higher rates of non-SBP infections, data presented by Jasmohan Bajaj Want to know more about SBP prophylaxis❓ Why or Why Not❓ Join me, as I deep dive into the evidence, at the Best of Liver Fellow Network session tomorrow 💫 🗓️

I announce to you a great joy; we have a Pope: The Most Eminent and Most Reverend Lord, Lord Robert Francis Cardinal of the Holy Roman Church Prevost who has taken the name Leo XIV. Cardinal Protodeacon Dominique Mamberti announces that the Cardinals have elected Cardinal Robert

Do we need to treat cirrhotic PVT, and how? – #EASL2025 🗣️ JC Garcia Pagan 📍 LT candidate → anticoagulate if >25% 🚫 No LT → consider if >50% 🔍 Anticoagulation may help beyond recanalization 🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH

It is a privilege to have Dr. Díaz as a speaker for our Seminar Series... Don't miss it! #LiverTwitter #LiverX AASLD EASLnews ALEH

Con la participación de más de 200 asistentes se llevó a cabo el V Curso de Hepatología General! Una iniciativa clave de Asociación Chilena de Hepatología para educar a médicos no especialistas y equipos de salud en el manejo de la cirrosis. AASLD EASLnews World Liver Day Soc. Chilena de Gastroenterología

🚀Don’t miss our new article in eGastroenterology! 🔗Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study 🗺️Pentoxifylline does not improve survival in patients with severe alcohol-associated hepatitis (sAH)

🧬New 📋 Veeral Ajmera Journal of Hepatology: In MASLD, inherited genetic risk drives age-associated fibrosis. ⬆️ LSMs after 40y in high-risk genotypes 🧪 PNPLA3 genotyping may improve risk stratification 📈 Supports personalized medicine 🔗 doi.org/10.1016/j.jhep… Rohit Loomba UCSD Gastroenterology

It runs in families. Dr. Tu shows that having a PARENT die from alcohol-related liver diseases puts the CHILD at higher risk of alcohol misuse and worse outcomes from alcohol-associated hepatitis Nature or Nurture? The answer is yes.

La Cirrosis se incluirá a patologías GES (Garantía Explícitas de Salud) en Chile! Un tremenda noticia que permitirá asegurar el tratamiento y el seguimiento de nuestros pacientes independientes de su previsión de salud!!! 🙌🏼🙌🏼🙌🏼🙌🏼 images.app.goo.gl/sSWj2PyH6r6cCW…

Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-analysis - Still much work to do in this field- CGH cghjournal.org/article/S1542-…

1 in 5 with Alcohol Use Disorder develop fatty liver disease. Facts — so young adults can build healthier lives. 💜 Mind Your Liver. It Needs You.™ #mindyourliver #fattyliver #liverawareness #alcoholusedisorder